Deficiency of protein tyrosine phosphatase non-receptor type 2 in intestinal epithelial cells has no appreciable impact on dextran sulphate sodium colitis severity but promotes wound healing by Kasper, Stephanie H et al.
Zurich Open Repository and
Archive
University of Zurich
Main Library
Strickhofstrasse 39
CH-8057 Zurich
www.zora.uzh.ch
Year: 2016
Deficiency of protein tyrosine phosphatase non-receptor type 2 in intestinal
epithelial cells has no appreciable impact on dextran sulphate sodium colitis
severity but promotes wound healing
Kasper, Stephanie H; Spalinger, Marianne R; Leonardi, Irina; Gerstgrasser, Alexandra; Raselli, Tina;
Gottier, Claudia; Atrott, Kirstin; Frey-Wagner, Isabelle; Fischbeck-Terhalle, Anne; Rogler, Gerhard;
Scharl, Michael
Abstract: BACKGROUND/AIMS The protein tyrosine phosphatase non-receptor type 2 (PTPN2) is
known to mediate susceptibility to inflammatory bowel diseases. Cell culture experiments suggest that
PTPN2 influences barrier function, autophagy and secretion of pro-inflammatory cytokines. PTPN2
knockout mice die a few weeks after birth due to systemic inflammation, emphasizing the importance of
this phosphatase in inflammatory processes. The aim of this study was to investigate the role of PTPN2
in colon epithelial cells by performing dextran sulphate sodium (DSS)-induced colitis in PTPN2xVilCre
mice. METHODS Acute colitis was induced by administering 2.5 or 2% DSS for 7 days and chronic colitis
by 4 cycles of treatment using 1% DSS. Body weight of mice was measured regularly and colonoscopy
was done at the end of the experiments. Mice were sacrificed afterwards and colon specimens were
obtained for Hamp;E staining. For analysis of wound healing, mechanical wounds were introduced during
endoscopy and wound closure assessed by daily colonoscopy. RESULTS Although colonoscopy and weight
development suggested changes in colitis severity, the lack of any influence of PTPN2 deficiency on
histological scoring for inflammation severity after acute or chronic DSS colitis indicates that colitis
severity is not influenced by epithelial-specific loss of PTPN2. Chronic colitis induced the development
of aberrant crypt foci more frequently in PTPN2xVilCre mice compared to their wild type littermates.
On the other hand, loss of PTPN2-induced enhanced epithelial cell proliferation and promoted wound
closure. CONCLUSIONS Loss of PTPN2 in intestinal epithelial cells (IECs) has no significant influence
on inflammation in DSS colitis. Obviously, loss of PTPN2 in IECs can be compensated in vivo, thereby
suppressing a phenotype. This lack of a colitis-phenotype might be due to enhanced epithelial cell
proliferation and subsequent increased wound-healing capacity of the epithelial layer.
DOI: https://doi.org/10.1159/000445289
Posted at the Zurich Open Repository and Archive, University of Zurich
ZORA URL: https://doi.org/10.5167/uzh-134538
Veröffentlichte Version
Originally published at:
Kasper, Stephanie H; Spalinger, Marianne R; Leonardi, Irina; Gerstgrasser, Alexandra; Raselli, Tina;
Gottier, Claudia; Atrott, Kirstin; Frey-Wagner, Isabelle; Fischbeck-Terhalle, Anne; Rogler, Gerhard;
Scharl, Michael (2016). Deficiency of protein tyrosine phosphatase non-receptor type 2 in intestinal
epithelial cells has no appreciable impact on dextran sulphate sodium colitis severity but promotes wound
healing. Digestion, 93(4):249-259.
DOI: https://doi.org/10.1159/000445289
2
E-Mail karger@karger.com
 Original Paper 
 Digestion 2016;93:249–259 
 DOI: 10.1159/000445289 
 Deficiency of Protein Tyrosine Phosphatase 
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specimens were obtained for H&E staining. For analysis of 
wound healing, mechanical wounds were introduced dur-
ing endoscopy and wound closure assessed by daily colo-
noscopy.  Results: Although colonoscopy and weight devel-
opment suggested changes in colitis severity, the lack of any 
influence of PTPN2 deficiency on histological scoring for in-
flammation severity after acute or chronic DSS colitis indi-
cates that colitis severity is not influenced by epithelial-spe-
cific loss of PTPN2. Chronic colitis induced the development 
of aberrant crypt foci more frequently in PTPN2xVilCre mice 
compared to their wild type littermates. On the other hand, 
loss of PTPN2-induced enhanced epithelial cell proliferation 
and promoted wound closure.  Conclusions: Loss of PTPN2 
in intestinal epithelial cells (IECs) has no significant influence 
on inflammation in DSS colitis. Obviously, loss of PTPN2 in 
IECs can be compensated in vivo, thereby suppressing a phe-
notype. This lack of a colitis-phenotype might be due to en-
hanced epithelial cell proliferation and subsequent in-
creased wound-healing capacity of the epithelial layer. 
 © 2016 S. Karger AG, Basel 
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 Abstract 
 Background/Aims: The protein tyrosine phosphatase non-
receptor type 2 (PTPN2) is known to mediate susceptibility 
to inflammatory bowel diseases. Cell culture experiments 
suggest that PTPN2 influences barrier function, autophagy 
and secretion of pro-inflammatory cytokines. PTPN2 knock-
out mice die a few weeks after birth due to systemic inflam-
mation, emphasizing the importance of this phosphatase in 
inflammatory processes. The aim of this study was to inves-
tigate the role of PTPN2 in colon epithelial cells by perform-
ing dextran sulphate sodium (DSS)-induced colitis in 
 PTPN2xVilCre mice.  Methods: Acute colitis was induced by 
administering 2.5 or 2% DSS for 7 days and chronic colitis by 
4 cycles of treatment using 1% DSS. Body weight of mice was 
measured regularly and colonoscopy was done at the end of 
the experiments. Mice were sacrificed afterwards and colon 
 Received: August 24, 2015 
 Accepted: March 7, 2016 
 Published online: April 27, 2016 
 PD Dr. med. Michael Scharl 
 Division of Gastroenterology and Hepatology 
 University Hospital Zurich 
 Rämistrasse 100, CH–8091 Zurich (Switzerland) 
 E-Mail michael.scharl   @   usz.ch 
 © 2016 S. Karger AG, Basel
0012–2823/16/0934–0249$39.50/0 
 www.karger.com/dig 
D
ow
nl
oa
de
d 
by
: 
Un
ive
rs
itä
t Z
ür
ich
,  
Ze
nt
ra
lb
ib
lio
th
ek
 Z
ür
ich
   
   
   
 
13
0.
60
.4
7.
25
 - 
2/
13
/2
01
7 
3:
05
:2
8 
PM
 Kasper   et al. Digestion 2016;93:249–259
DOI: 10.1159/000445289
250
 Introduction 
 Crohn’s disease (CD) and ulcerative colitis (UC) are 
the most common types of inflammatory bowel diseases 
(IBD), a group of chronic and relapsing inflammatory 
conditions of the intestine. Even though the multifacto-
rial pathogenesis is still not entirely understood, it is 
 generally accepted that IBD results from an excessive 
 inflammatory immune response to otherwise commensal 
microbiota in genetically predisposed individuals. Ge-
nome-wide association studies helped to identify over 
160 susceptibility loci for IBD  [1] . Among these loci is the 
gene encoding protein tyrosine phosphatase non-recep-
tor type 2 (PTPN2) that has also been reported to be 
linked to other autoimmune diseases such as diabetes 
type 1 and rheumatoid arthritis  [2–4] .
 Similar to other phosphatases, PTPN2 is a negative 
regulator of many signalling pathways. It interferes with 
cytokine signalling by dephosphorylating some JAK and 
STAT molecules  [5–7] and participates in growth regula-
tion and glucose homeostasis by targeting EGFR and in-
sulin receptor  [5] . PTPN2 is a ubiquitously expressed pro-
tein that can be found in most mammalian embryonic 
and adult tissues with higher levels observed in lymphoid 
cells. In accordance with its potential role as IBD suscep-
tibility gene, PTPN2 expression was found to be increased 
in intestinal biopsies of CD patients and to a lower extent 
also in UC patients  [8] . Global loss of PTPN2 is lethal: 
 PTPN2 –/– mice show defects in haematopoiesis, anaemia, 
massive tissue infiltration by mononuclear cells and die a 
few weeks after birth  [9, 10] . The embryonic development 
of these mice seems normal, the newborns are of normal 
size and health. Nevertheless, at the age of 3 weeks, they 
are obviously smaller compared to their wild type (wt) lit-
termates and exhibit hunching, closed eyes, decreased 
mobility and diarrhoea followed by death  [9] .
 From cell culture experiments using intestinal epithe-
lial cell (IEC) lines it is already known that PTPN2 expres-
sion is increased by the pro-inflammatory cytokines TNF 
and IFNγ  [8, 11, 12] . Knock down of PTPN2 potentiates 
the stimulatory effects of TNF and IFNγ leading to exag-
gerated epithelial permeability and amplified secretion of 
interleukin (IL)-6 and IL-8  [8, 11, 12] . PTPN2 also regu-
lates autophagy: loss of PTPN2 leads to impaired au-
tophagosome formation and dysfunctional autophagy in 
IECs  [13] . Without functional autophagy IECs are more 
prone to infection by intracellular invaders like  Listeria 
monocytogenes  [13] .
 The above-mentioned in vitro findings show the im-
portance of PTPN2 in IECs and the knockout mouse 
demonstrates that PTPN2 also plays a role in inflamma-
tory processes in vivo. Therefore, we investigated the in 
vivo role of PTPN2 in the intestinal epithelium. To do so, 
we generated a mouse strain with a tissue specific loss of 
PTPN2 in IECs. The mice carry loxP sequences flanking 
exon 3 of the PTPN2 gene and express Cre-recombinase 
under the control of the vilin promotor. We used these 
PTPN2 flox/flox xVilCre mice to perform acute and chronic 
dextran sulphate sodium (DSS)-induced colitis. Regard-
ing the preliminary mentioned data, we expected these 
mice to suffer from more severe inflammation upon DSS 
treatment.
 Materials and Methods 
 Mice and Induction of Colitis 
 Animal experiments were carried out according to Swiss an-
imal welfare laws and were approved by the veterinary authori-
ties of Zurich, Switzerland (Kanton Zürich Gesundheitsdirek-
tion Veterinäramt, approval No. 54/2011). Due to the approval 
of the veterinary authorities of Zurich, no further approval by an 
Institutional Animal Care and Use Committee or Ethics Com-
mittee was necessary. Mice were housed in a specific pathogen-
free facility in individually ventilated cages. Food and water were 
available ad libitum. Female PTPN2 flox/flox (referred to as wt) and 
PTPN2 flox/flox VilCre (referred to as knockout, ko) littermates on 
a C57BL/6J background were used for all experiments. Mice with 
a bodyweight between 20 and 25 g were randomly divided into 
2 DSS and 2 water control groups. Acute colitis was induced by 
administering 2.5 or 2% DSS (MP Biomedicals, Illkirch, France) 
dissolved in drinking water for 7 days. Chronic colitis was in-
duced by 4 cycles of treatment with 1.5% DSS for 7 days inter-
spersed with 10 days of regular drinking water and a final recov-
ery phase of 3.5 weeks. Body weight and disease activity were 
determined regularly. At the end of the experiment, colonoscopy 
was performed in a blinded manner and mice were subsequent-
ly sacrificed. Spleen and colon were removed, and colon length 
and spleen weight were measured. Colon samples were collected 
for H&E staining at days 3 and 7.
 Assessment of Colonoscopy Score in Mice 
 Animals were anaesthetised intraperitoneally with 90–120 mg/
kg body weight ketamine (Vétoquinol, Bern, Switzerland) and 
8 mg/kg body weight xylazine (Bayer, Lyssach, Switzerland). Colo-
noscopy was done as described previously  [14] . Briefly, the solid 
endoscope was introduced per anus with a lubricant (2% lido-
caine) in the sedated mouse. The colon was gently inflated with air. 
Recording was performed with the Karl Storz Tele Pack Pal 
20043020 (Karl Storz Endoskop, Tuttlingen, Germany). Colonos-
copy was scored using the murine endoscopic index of colitis se-
verity (MEICS) scoring system as described previously  [14] . The 
following parameters were assessed in detail: (1) thickening of the 
colon wall (transparent, moderate, marked, non-transparent 0–3 
points), (2) changes of the vascular pattern (normal, moderate, 
marked, bleeding 0–3 points), (3) fibrin visible (none, little, 
marked, extreme 0–3 points), (4) granularity of the mucosal sur-
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face (none, moderate, marked, extreme 0–3 points) and (5) stool 
consistency (normal solid, still shaped, unshaped, spread 0–3 
points). This results in an overall MEICS score range between 
0 and 15.
 Assessment of Histological Score in Mice 
 Histological scoring for inflammatory infiltration and epithe-
lial cell damage were performed on H&E-stained sections of the 
most distal 1 cm of the mouse colon as described previously  [15] . 
Score for epithelial damage: 0, normal morphology; 1, loss of gob-
let cells; 2, loss of goblet cells in large areas; 3, loss of crypts; 4, loss 
of crypts in large areas. Score for infiltration: 0, no infiltrate; 1, in-
filtrate around crypt base; 2, infiltrate reaching to  L. muscularis 
mucosae; 3, extensive infiltration reaching the  L. muscularis and 
thickening of the mucosa with abundant oedema; 4, infiltration of 
the  L. submucosae . The total histological score represents the sum 
of the scores for epithelial damage and infiltration. Histological 
examination was performed by an independent, blinded investiga-
tor.
 IEC and DNA Isolation from Colon Specimens 
 After removing the most distal 3 cm of colon for other pur-
poses, the remaining part of the colon was cut lengthwise, freed 
from residual faeces and cut into small pieces. To loosen IEC, the 
slices were transferred to Hank’s balanced salt solution (HBSS; 
PAA, Linz, Austria) supplemented with 2 m M of EDTA and 
stirred for 30 min at 37  °  C. Mucosal pieces were removed by pass-
ing the slurry over a coarse mesh (400 μm; Carl Roth GmbH, 
Karlsruhe, Germany). The sieve residue was flushed back to the 
tube with fresh HBSS, vigorously shaken 10 times and vortexed 
for 1 min. The shake and vortex step was repeated 2 times result-
ing in 30 times shaking and 3 min of vortexing. Mucosal pieces 
were partitioned again from detached cells by filtration through 
mesh. Through fraction was collected and centrifuged at 400  g for 
7 min. Supernatant was discarded and the cell pellet was resus-
pended in PBS. The supernatant was removed and samples were 
frozen in liquid nitrogen and stored at –80   °   C until DNA, RNA 
or protein isolation. The pelleted IECs were thawed and DNA 
was isolated using the DNA Mini Kit (Qiagen, Düsseldorf, 
 Germany) based on the manufacturer’s blood and body fluid spin 
protocol.
 RNA Isolation, RT-PCR and Quantitative PCR 
 To isolate RNA, IEC were isolated as described above and re-
suspended in 350 μl RLT buffer (Qiagen, Venlo, Netherlands). For 
RNA isolation from colon tissue, 1 cm long colon pieces were lysed 
in 350 μl RLT buffer in gentleMACS tissue disrupter tubes (Milt-
enyi Biotec, Bergisch Gladbach, Germany) by adhering to the 
manufacturer’s instructions. Total RNA was isolated using RNeasy 
Plus Mini Kit (Qiagen) according to manufacturer’s instructions. 
RNA concentration was measured by absorbance at 260 and 
280 nm. Complementary DNA (cDNA) synthesis was performed 
using a high-capacity cDNA reverse transcription kit (Life Tech-
nologies, Foster City, Calif., USA) following the manufacturer’s 
instructions. Real-time polymerase chain reaction (PCR) was per-
formed using FAST qPCR MasterMix for Taqman assays (Life 
Technologies) on a Fast HT7900 Real-Time PCR system using SDS 
software (Life Technologies). Measurements were performed in 
triplicate, mouse β-actin was used as endogenous control, and re-
sults were analyzed by ΔΔCT method. The real-time PCR con-
tained an initial enzyme activation step (5 min, 95  °  C) followed by 
45 cycles consisting of a denaturing (95  °  C, 15 s) and an annealing/
extending (60   °   C, 1 min) step. The used gene expression assays 
were all obtained from Life Technologies.
 Protein Isolation and Western Blotting 
 IEC isolated as described above, or 1 cm long colon pieces tak-
en 1 cm proximally from the rectum, were homogenized in M-PER 
cell lysis buffer (Thermo Fisher Scientific, Waltham, Mass., USA) 
using gentleMACS tissue disrupter tubes (Miltenyi Biotec) accord-
ing to the manufacturer’s instruction. The homogenates were lysed 
for 30 min on ice and centrifuged for 10 min to remove cell debris. 
Equal amounts of protein from each lysate were loaded on poly-
acrylamide gels and after separation by gel-electrophoresis blotted 
onto nitrocellulose membranes. Membranes were incubated over 
night with anti-mouse PTPN2 antibody (Merck Millipore, Biller-
ica, Mass., USA), washed 3 times with washing buffer (tris buffered 
saline, 3% milk) before incubation with HRP-coupled anti-mouse 
secondary antibody (Santa Cruz Biotechnologies, Dallas, Tex., 
USA) for 2 h. Immunoreactive proteins were detected with a Fu-
sion Solo S imager (Vilber Lourmat, Eberhardzell, Germany) using 
an enhanced chemiluminescence detection kit (GE Healthcare, 
Little Chalfont, UK).
 Immunohistochemistry 
 Immunohistochemical studies were performed on formalin-
fixed, paraffin-embedded tissue specimen using a peroxidase-
based method with diaminobenzidine (DAB) chromogen. Tissue 
samples were incubated with xylol and descending concentra-
tions of ethanol. Antigen retrieval was performed using citrate 
buffer, pH 6.0 (DAKO, Glostrup, Denmark) for 30 min at 98  °  C. 
Endogenous peroxidases were deleted by incubation with 0.9% 
hydrogen peroxide for 15 min at room temperature (RT) and 
blocking was performed using 3% bovine serum albumin over-
night in a wet chamber. Sections were stained for 2 h at RT with 
an appropriate concentration of mouse anti-PTPN2 antibody 
(Merck Millipore). HRP-labelled secondary anti-mouse IgG-an-
tibody (Santa Cruz Biotechnology) was applied for 1 h at RT and 
antibody binding visualized by a liquid DAB+ substrate chromo-
gen system (DAKO). Then samples were counterstained with 
haematoxylin, dehydrated in ascending concentrated ethanol and 
xylol solutions and finally mounted. Microscopic assessment was 
done using an AxioCam HRc (Zeiss, Jena, Germany) on a Zeiss 
Axio Imager. Z2 microscope (Zeiss) with AxioVision release 4.8.2 
software (Zeiss).
 Genotyping 
 Digestion buffer (25 m M NaOH, 0.2 m M EDTA) was added to 
ear biopsies and incubated for 1 h at 98   °   C. An equal amount of 
neutralisation buffer (40 m M Tris-HCl, pH 5.5) was added and 1 μl 
was used for genotyping VilCre PCR to assess the presence of the 
cre-recombinase. DNA isolated from IECs from colon specimens 
was used to check if cre-mediated recombination took place via 
genotyping PCR. Primer sequences VilCre PCR: VilCre_forward: 
GTGTGGGACAGAGAACAAACC, VilCre_reverse: ACATCTTC 
AGGTTCTGCGGG, Contr_forward: CAAATGTTGCTTGTCT 
GGTG, Contr_reverse: GTCAGTCGAGTGCACAGTTT; primer 
sequences for PTPN2 recombinant allele: primer_forward: GCC 
AAGAGACAGTGGAAAGAGAG, Primer_reverse: ACTGCAA 
AACCATAACTGGGC.
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 Wound Healing Assay 
 For the in vitro wound-healing assay, HT-29 cells (DSMZ, 
 Germany) were transfected with non-targeting control, or PTPN2 
specific siRNA (Life Technologies) using an Amaxa nucleofector 
(Lonza, Basel, Switzerland) prior to seeding at a density of 1 × 10 6 
cells/ml in 6 well plates. Cells were grown for 2 days to reach full con-
fluency before generating a scratch using a pipette tip. Closure of the 
scratch area was monitored using a bright field microscope (Zeiss).
 The in vivo wound-healing model was performed as described 
 [16] : during endoscopy, mucosal wounds were induced mechani-
cally using a biopsy forceps with a diameter of 3 French (equals 
1 mm). Subsequently, wound healing was monitored by daily en-
doscopy and quantified by measurement of the residual wound 
area using ImageJ image processing software. The individual 
wound closure over time was calculated by dividing actual wound 
area/initial wound area and is presented as percentage.
 Results 
 Mice with Tissue Specific Loss of PTPN2 in IECs 
 To determine the role of the IBD susceptibility gene 
PTPN2 in the intestinal epithelium in vivo, we gener-
ated mice that exhibited a tissue-specific loss of PTPN2 
in IECs (PTPN2 flox/flox xVilCre mice). To confirm cre-
recombinase mediated recombination of the PTPN2 al-
lele, PTPN2 flox/flox and PTPN2 flox/flox xVilCre mice were 
sacrificed and IECs were isolated from colon  specimens. 
DNA was isolated from these IECs and used for geno-
typing PCR. In fact,  figure 1 shows that cre-recombi-
nase was active in PTPN2 flox/flox xVilCre mice and medi-
ated conversion of the PTPN2 allele in IECs. Further, 
immunohistochemistry (IHC) confirmed loss of PTPN2 
protein expression in IEC in health and after induction 
of acute colitis using 2.5% DSS for 7 days ( fig.  1 b). 
While only a slight reduction of PTPN2 mRNA 
 expression was found in the colon, its expression was 
lost in isolated IEC ( fig. 1 c). Similar results were ob-
tained when analysing PTPN2 protein expression by 
western blot ( fig. 1 d). Of note, PTPN2 expression was 
enhanced in the colon and in IEC of DSS-treated 
PTPN2 flox/flox animals, but not in PTPN2 flox/flox xVilCre 
mice ( fig. 1 c, d).
 Fig. 1. Loss of PTPN2 in IECs of PTPN2xVilCre mice.  a IECs were 
isolated from colon specimens of PTPN2 flox/flox xVilCre (ko) and 
PTPN2 flox/flox (wt) mice. DNA was isolated from these IECs and 
used for genotyping PCR. Amplified PCR products were run in a 
3% agarose gel and 100 bp DNA ladder was used to estimate am-
plicon lengths.  b–d wt and ko mice were treated for 7 days with 
2.5% DSS to induce acute colitis and terminal colon tissue was 
stained for PTPN2 by IHC ( b ); colon lysates or isolated IECs were 
analysed for PTPN2 mRNA expression by RT-PCR ( c ); and 
PTPN2 protein levels by western blotting ( d , e). Asterisks denote 
significant differences ( *  p < 0.05,  * *  p < 0.01,  * * *  p < 0.001, Neu-
wmann Keul’s test). 
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 PTPN2xVilCre Mice Tended to Suffer More from 
Acute Colitis Induced by 2.5% DSS 
 The DSS-induced colitis, a model of mucosal inflam-
mation to study IBD pathogenesis, was used for experi-
mental approaches. In a first acute colitis experiment 
we  administered 2.5% DSS to PTPN2 flox/flox xVilcre 
 (PTPN2xVilCre) mice and their PTPN2 flox/flox (wt) litter-
mates for 7 days. The DSS treatment induced severe 
weight loss in both groups ( fig. 2 a). At the end of the ex-
periment there was no difference in weight loss between 
genotypes but the onset of weight loss was earlier in the 
DSS-treated PTPN2xVilCre animals compared to their 
DSS-treated wt littermates, leading to a significant differ-
ence at day 3 ( fig. 2 a). Colonoscopy at day 3 as well as at 
the end of the experiment revealed significant difference 
between DSS groups, with PTPN2xVilCre mice showing 
signs of a more severe inflammation ( fig. 2 b). Further, we 
scored H&E-stained colon slides for infiltration and epi-
thelial damage. While histology at day 3 revealed slightly 
enhanced colitis in PTPN2xVilCre animals, no difference 
could be detected at day 7. Nevertheless, the score re-
vealed a very severe inflammation at day 7 even in the 
DSS-treated wt group with one mouse reaching a maxi-
mum score of 8. Colitis induction further led to a marked 
shortening of the colon at day 7, but the magnitude was 
not influenced by PTPN2 deficiency in IEC ( fig. 2 c). Also, 
at day 7 the spleen weight was increased indicative of a 
very severe DSS-induced inflammation in both, wt and 
PTPN22xVilCre animals ( fig. 2 d). Therefore, it seemed 
plausible that wt animals already showed such a pro-
nounced inflammation that it was not possible for the 
PTPN2xVilCre group to exceed their inflammation. 
 Fig. 2. PTPN2xVilCre mice tended to exhibit more severe inflamma-
tion in acute colitis using 2.5% DSS. Female PTPN2 flox/flox xVilCre 
(ko) and their PTPN2 flox/flox (wt) littermates received 2.5% DSS for 7 
days and body weight was measured daily. To assess colitis severity, 
colonoscopy was performed at days 3 and 7 of the experiments, and 
mice were sacrificed at day 3 (n = 6) and day 7 (n = 8) to assess his-
tological changes.  a Weight changes in percent indicate early onset 
of weight loss in PTPN2xVilCre mice, data are presented as mean ± 
SD.  b Representative pictures from colonoscopy at days 3 and 7 
 indicate more severe disease in ko animals, while H&E-stained 
 sections from the distal colon reveal no difference ( c ).  d Accord-
ingly, MEICS show more severe DSS-induced inflammation in 
 PTPN2xVilCre mice, but quantification of H&E-stained sections ( e ) 
reveal no difference. Colon length ( f ) and Spleen weight ( g ) were 
measured but both parameters were not influenced by genotype.  d–
g The values for individual mice, horizontal bars indicate mean, 
Mann–Whitney U test was used for statistical analysis,  *  p < 0.05, 
 * *  p < 0.001. 
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Hence, we decided to lower the DSS concentration in a 
second acute DSS colitis experiment, to investigate 
whether the differences between wt and PTPN2xVilCre 
mice would be more pronounced during a more moder-
ate colitis.
 PTPN2 Deficiency in IECs Did Not Influence 
Inflammation in Acute Colitis Induced by 2% DSS 
 A milder colitis was induced by the administration of 
2% DSS for 7 days and the resulting weight curve is shown 
in  figure 3 a. Regarding weight loss, we did not detect any 
differences between equally treated groups during the 
whole experiment ( fig. 3 a). In contrast to the 2.5% DSS 
colitis, the early onset of weight loss in the DSS-treated 
PTPN2xVilCre mice did not reoccur when using less 
DSS. Also, colonoscopy and histologic assessment of mi-
croscopic disease severity as well as the respective scores 
did not reveal significant differences between genotypes, 
neither at day 3 nor at day 7 of the experiment ( fig. 3 b–e). 
There was only a minor trend towards a more severe in-
flammation in PTPN2 ko animals. The DSS treatment re-
sulted in the shortening of the colon and increased spleen 
weight induced by inflammation but was independent of 
the genotype ( fig. 3 f, g). Interestingly, the variation with-
in DSS groups was extremely high and some animals even 
showed normal healthy mucosa.
 PTPN2xVilCre Mice Tended to Suffer Less from 
Chronic DSS Colitis 
 To see whether a prolonged inflammation would re-
veal a phenotype in PTPN2xVilCre mice, we performed 
a chronic colitis experiment by 4 cycles of DSS treatment 
and a final recovering phase of 4 weeks. The weight curve 
( fig. 4 a) revealed no significant differences. Surprisingly, 
during acute phases, the weight loss of PTPN2xVilCre 
mice tended to be less pronounced compared to their wt 
littermates. This unexpected trend was also visible in the 
colonoscopic scoring: DSS-treated PTPN2 ko animals 
showed significantly less severe inflammation compared 
to their wt littermates ( fig. 4 b). This unexpected differ-
 Fig. 3. No differences in inflammation severity in acute colitis using 
2% DSS. Female PTPN2 flox/flox xVilCre (ko) and their PTPN2 flox/flox 
(wt) littermates received 2% DSS for 7 days (n = 4/5). Body weight 
was measured daily and ( a ) percental weight changes are presented 
as mean ± SD.  b–e At day 3 (n = 3) and day 7 (n = 4/5) colonos-
copy was performed and MEICS was used to determine inflamma-
tion severity. On these days, mice were also sacrificed and terminal 
colon assessed for histological changes.  b Representative colono-
scopic pictures;  c representative pictures from H&E-stained sec-
tions of the terminal colon;  d MEICS;  e histological scores show no 
influence of PTPN2 deficiency. Colon length ( f ) and spleen weight 
( g ) was measured but both parameters were not altered by geno-
type.  b–g The values for individual mice, horizontal bars indicate 
mean, Mann–Whitney U test was used for statistical analysis. 
Co
lor
 ve
rsio
n a
vai
lab
le o
nlin
e
0 1 2 3 4 5 6 7
–15
–10
–5
0
5
Days of treatment
W
ei
gh
t c
ha
ng
e 
(%
)
wt H2O
ko H2O
wt DSS
ko DSS
a
b
c
H2O 3 days DSS
wt ko wt ko wt ko
7 days DSS
0
2
4
6
8
10
12
M
EI
CS
wt ko wt ko
H2O 3 days DSS
wt ko
5 days DSSd
0
2
4
6
8
10
12
H
is
to
lo
gi
ca
l s
co
rin
g
wt ko wt ko
H2O 3 days DSS
wt ko
5 days DSSe
wt ko wt ko
H2O 3 days DSS
wt ko
5 days DSS
0
2
4
6
8
10
12
Co
lo
n 
le
ng
th
 (c
m
)
f
0
0.05
0.10
0.15
0.20
Sp
le
en
 w
ei
gh
t (
g)
wt ko wt ko
H2O 3 days DSS
wt ko
5 days DSSg
D
ow
nl
oa
de
d 
by
: 
Un
ive
rs
itä
t Z
ür
ich
,  
Ze
nt
ra
lb
ib
lio
th
ek
 Z
ür
ich
   
   
   
 
13
0.
60
.4
7.
25
 - 
2/
13
/2
01
7 
3:
05
:2
8 
PM
 PTPN2 Deficiency in IECs Does Not 
Influence Inflammation in DSS Colitis 
Digestion 2016;93:249–259
DOI: 10.1159/000445289
255
ence was not reflected in the histological scoring of 
 H&E-stained colon slides ( fig. 5 a). Histology did not even 
show a trend but rather the same degree of mucosal dam-
age in both DSS groups. However, H&E-stained sections 
showed epithelial abnormalities in DSS-treated mice that 
were not observed in acute colitis experiments. Several 
aberrant crypts of different shapes formed clusters that 
were clearly distinguished from the surrounding tissue 
( fig. 5 b). Aberrant crypt foci like that are known to be a 
consequence of aberrant proliferation upon exposure to 
carcinogens and could develop into colon cancer  [17, 18] . 
Importantly, the aberrant crypt foci were significantly 
more frequent in DSS-treated PTPN2xVilCre mice 
( fig. 5 b). In one mouse, abnormal foci even penetrated the 
lamina muscularis and aberrant crypts were found in the 
submucosa.
 IEC-Specific Loss of PTPN2 Promotes IEC 
Proliferation and Wound Healing 
 So far we observed that PTPN2xVilCre mice suffered 
from a more severe colitis at day 3 of 2.5% DSS treatment 
but seemed to be able to compensate for this early weight 
loss. Further, PTPN2xVilCre mice tended to suffer less in 
chronic DSS-induced colitis, and showed aberrant crypt 
proliferation. Hence, we hypothesized that IEC-specific 
loss of PTPN2 might in general influence epithelial pro-
liferation and wound-healing mechanisms. To address 
this hypothesis, we first used an in vitro model for prolif-
eration and wound healing, where a scratch is induced in 
a confluent monolayer of HT29 IEC and the closure of the 
scratch is monitored. While in control siRNA transfected 
cells the scratch width was still 30–50% of the initial dis-
tance after 48 h, transfection with PTPN2 specific siRNA 
resulted in almost complete closure of the gap in the same 
time period (5–15% of initial width;  fig. 6 a). This indi-
cates that loss of PTPN2 in epithelial cells might indeed 
affect proliferation and wound closure. To further assess 
this hypothesis, we next stained intestinal specimen from 
wt and PTPN2xVilCre mice from the 2.5% DSS colitis 
experiment (day 7) for Ki67, a general marker for cell pro-
liferation. In wt animals, only a few Ki67 positive cells 
were detected, although Ki67 staining was increased upon 
DSS treatment. In PTPN2xVilCre animals, there were el-
evated levels of Ki67+ cells even in the healthy colon, and 
numbers further increased upon colitis induction ( fig. 6 b). 
To finally address whether in vivo wound healing is af-
 Fig. 4. PTPN2xVilCre mice tended to exhibit less severe inflam-
mation in chronic DSS colitis. Female PTPN2 flox/flox xVilCre (ko) 
and their PTPN2 flox/flox (wt) littermates received 4 cycles of DSS 
treatment and were allowed to recover afterwards for 3.5 weeks 
(n = 7/8). Body weight was measured regularly and ( a ) percental 
weight changes are presented as mean ± SD. Colonoscopy was 
done at the end of the experiment and MEICS was used to deter-
mine inflammation severity.  b Representative colonoscopic pic-
tures and MEICS show less severe inflammation in mice with 
PTPN2 deficiency in IECs. Mice were sacrificed; colon length ( c ) 
and spleen weight ( d ) were measured but both parameters were 
not altered by genotype.  b–d The values for individual mice, hori-
zontal bars indicate mean, Mann–Whitney U test was used for 
statistical analysis,  *  p < 0.05. 
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fected upon loss of PTPN2 in IEC, we used an in vivo 
model for wound healing, where a small epithelial wound 
is mechanically induced in the colon epithelium and 
wound closure measured daily by endoscopy. In this 
model, we found a strong trend towards faster wound clo-
sure in PTPN2xVilCre mice when compared to their wt 
littermate controls ( fig. 6 c).
 Discussion 
 In the first acute colitis experiments, we observed an 
early onset of weight loss in DSS-treated PTPN2xVilCre 
mice compared to their wt littermates and colonoscopy 
showed significantly more severe inflammation in those 
animals. In a second experiment using a lower DSS con-
centration, these differences did not reoccur. In a chron-
ic DSS colitis, mice with PTPN2 deficiency in IECs tend-
ed to less pronounced weight loss during acute phases 
and colonoscopy revealed less severe inflammation by the 
end of the experiment. In all 3 experiments, histological 
scoring did not show any differences between genotypes. 
The fact that histological scoring is regarded as the gold 
standard in evaluation of inflammation severity debili-
tates the differences we found in weight loss or colonos-
copy. Obviously, in the context of DSS colitis PTPN2 
plays only a minor role in IECs during inflammation.
 These findings are apparently in contrast to cell culture 
studies that demonstrated the importance of PTPN2 ex-
pression in IECs for barrier function, secretion of pro-in-
flammatory cytokines and autophagy  [8, 11–13] , what 
seems to have no apparent in vivo effects. The mechanism 
of DSS-induced inflammation involves erosion of the epi-
thelial barrier  [19, 20] , generating breaches where patho-
gens and commensals can enter and elicit a strong immune 
reaction  [21] . During intestinal inflammation, the ability of 
IECs to proliferate and regenerate is crucial for the restora-
tion of the integrity of the mucosal barrier and termination 
of inflammation  [22] . Therefore, increased IEC prolifera-
tion and more efficient wound healing might explain why 
 Fig. 5. PTPN2xVilCre mice developed more frequently aberrant 
crypt foci in chronic DSS colitis. To induce chronic colitis 
PTPN2 flox/flox xVilCre (ko) and their PTPN2 flox/flox (wt) littermates 
received 4 cycles of DSS treatment and were allowed to recover 
afterwards for 3.5 weeks (n = 7/8). At the end of the experiment, 
mice were sacrificed and distal colon slides were used for H&E 
staining and scored for epithelial damage and infiltration.  a Rep-
resentative pictures and graph presenting histological score exhib-
it no difference between genotypes. Graph shows values for indi-
vidual mice, horizontal bars indicate mean.  b Aberrant crypt foci 
were detected more frequently in H&E-stained slides of distal co-
lon in ko mice. 
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 Fig. 6. Loss of PTPN2 in IEC promotes proliferation and intestinal 
wound closure.  a HT29 cells were transfected with non-targeting 
control or with PTPN2-specific siRNA and grown to confluency. 
A scratch was induced and closure of the scratch monitored at in-
dicated time-points. Representative pictures and quantification of 
the relative scratch width indicate faster closure in PTPN2-defi-
cient HT-29.  b Female PTPN2 flox/flox xVilCre (ko) and their 
PTPN2 flox/flox (wt) littermates received 2.5% DSS for 7 days. Sec-
tions from the distal colon were stained for the proliferation mark-
er Ki67, and this reveals increased IEC proliferation in ko animals 
( c ). Mucosal wounds were introduced in ko and wt littermates and 
wound closure monitored by daily endoscopy. Representative pic-
tures and statistical analysis of relative wound closure show a 
strong trend toward increased wound healing in ko animals. 
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IEC-specific deletion of PTPN2 does not result in increased 
pathology upon DSS treatment. Although lack of PTPN2 
in IEC might result in defective epithelial barrier functions 
 [11] or enhanced secretion of pro-inflammatory cytokines 
 [23, 24] , increased proliferation can obviously compensate 
for those effects. EGFR is among the known targets of 
PTPN2  [5] , which might explain the increased prolifera-
tion in PTPN2-deficient IEC. Also ERK and p38 – both 
targets of PTPN2 in IEC  [23, 25] – have been implicated in 
IEC proliferation  [26, 27] . However, further analysis would 
be necessary to address the molecular mechanisms as to 
how loss of PTPN2 mediates increased proliferation.
 Further, DSS-induced inflammation is mediated by 
the interplay of many different cells types, not only IECs 
but also cells of the innate and adaptive immune system. 
When PTPN2 function is lost in IECs, the body seems to 
be able to compensate this shortcoming. However, in vivo 
studies using other tissue-specific PTPN2 knock out 
mouse strains have already demonstrated the importance 
of this phosphatase for the development of CD4 + cells 
 [28] but also for TCR signalling and lymphopenia-in-
duced proliferation in CD8 + cells  [29, 30] . Apparently, 
loss of PTPN2 in the T cell compartment cannot be coun-
terbalanced and leads to strong phenotypes. This is not 
surprising regarding the fact that PTPN2 has the highest 
expression in T cells and was originally discovered in a 
screening of a human T cell cDNA library  [31] .
 After induction of chronic colitis, we detected epithe-
lial aberrant crypt foci in HE-stained sections of the distal 
colon in DSS-treated animals. This kind of epithelial 
transformations has been observed in other studies as a 
result of exposure to carcinogens and could develop into 
colon cancer  [17, 18] . Those abnormalities were present 
in most knockout animals but only in one wt mouse. This 
again fits to the increased proliferative capacity of IEC we 
observed upon loss of PTPN2. Further, the PTPN2 target 
EGFR is involved in tumour progression, and might be 
involved in the formation of aberrant crypts in our mice. 
In conclusion, these aberrant crypt foci further indicate 
that loss of PTPN2 in IEC might promote tumour pro-
gression. However, more detailed analysis will be neces-
sary to address this hypothesis.
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